|
|
|
| Imaging differences between drug-resistant and sensitive tuberculosis: A systematic review and meta-analysis |
| GAO Jinsong1, YAO Feng1, LI Jin1,3, ZHANG Jianhui1, Lei Mingsheng1,2 |
1. Zhangjiajie Hospital Affiliated to Hunan Normal University, Zhangjiajie 427000, China;
2. Jishou University Zhangjiajie College, Zhangjiajie 427000, China;
3. Medical College of Jishou University, Jishou 416000, China |
|
|
|
|
Abstract Objective Meta-analysis was used to evaluate the imaging characteristics of drug-resistant and sensitive tuberculosis and to analyze the differences. Methods We searched PubMed, Web of Science, and China National Knowledge Infrastructure using the following search terms: “multidrug-resistant tuberculosis”“computed tomography”“drug-sensitive tuberculosis”, in which the time limited was from the establishment of databases to March 2024. The experimental group comprised patients with confirmed drug-resistant tuberculosis based on pathogen or molecular biology criteria, while the control group consisted of individuals with drug-sensitive tuberculosis. Data extraction from the included literature encompassed details such as first author, publication year, drug resistance status, sample size, imaging features, etc. Quality assessment of the included studies was performed using the NOS scale. Meta-analysis was carried out using Stata MP 18 software. Begg′s and Egger′s tests were employed to evaluate publication bias. Results Ultimately, eleven articles were included in our analysis, comprising 1352 patients with drug-resistant tuberculosis and 1852 patients with sensitive tuberculosis. The results of meta-analysis showed that in the experimental group, the incidence of cumulative lesions ≥3 lung lobes (RR=1.32, 95%CI 1.26-1.39), the incidence of damaged lung (RR=5.02, 95%CI 3.59-7.01), and the incidence of cavities (RR=1.55, 95%CI 1.47-1.69), lung consolidation rate (RR=1.35, 95%CI 1.24-1.46), incidence of atectasis (RR=1.36, 95%CI 1.16-1.60), was higher than that of control group, and lesion absorption after treatment (RR=0.63, 95%CI 0.57-0.71) was lower than that of control group , the incidence of pleural effusion (RR=1.01, 95% CI 0.87-1.16) and the incidence of mediastinal lymph node enlargement (RR=1.09, 95% CI 0.94-1.26) showed no significant difference between the two groups. The funnel plot results indicated publication bias in three effect indicators: lesion distribution, lung consolidation, and mediastinal lymph node enlargement. Conclusion Drug-resistant tuberculosis differs from sensitive tuberculosis in the distribution of lesions, lesion morphology, dynamic changes in the disease, and changes in the mediastinal lymph nodes, which can help in early diagnosis.
|
|
Received: 03 April 2024
|
|
|
|
[1] 舒薇, 刘宇红. 世界卫生组织《2023年全球结核病报告》解读[J]. 结核与肺部疾病杂志, 2024, 5(1): 15-19.
[2] LANGE C, CHESOV D, HEYCKENDORF J, et al.Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment: Drug-resistant tuberculosis[J]. Respirology, 2018,23(7):656-673.
[3] ANASTASIA K, HELEN C, VALERIE M.Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment[J]. Curr Opin Pharmacol, 2018, 42: 7-15.
[4] 高德杰, 王束玫, 邱丽华.86例耐多药肺结核患者胸部影像分析[J]. 临床肺科杂志, 2012, 17(07): 1265-1266.
[5] 董琼雄, 蔡少怀, 李史来, 等.125例耐多药肺结核胸部影像学分析[J]. 中华全科医学, 2011, 9(03): 459-460.
[6] 李春华, 赵攀, 吕圣秀, 等.127例耐多药肺结核CT影像学改变与临床[J]. 重庆医学, 2014, 43(23): 3078-3080.
[7] 陈根铭, 成官迅, 朱少乾, 等. 初治单耐药肺结核的CT影像学研究[J]. 新发传染病电子杂志, 2018, 3(02): 111-114.
[9] 李政旻, 余辉山, 陈曼仙. 耐多药肺结核的影像学表现[C]//中华医学会, 中华医学会放射学分会. 中华医学会第十三届全国放射学大会论文汇编 (上册), 2006: 380-381.
[10] 罗伟军, 钟铖, 王静. 耐药结核分枝杆菌感染肺结核患者影像学特点及特征变化分析[J]. 影像研究与医学应用, 2021, 5(10): 219-220+222.
[11] 韩火平, 陈新. 耐药性肺结核病影像学特征性改变的临床研究[J]. 中国医学创新, 2020, 17(17): 32-35.
[12] YEOM J A, JEONG Y J, JEON D, et al.Imaging findings of primary multidrug-resistant tuberculosis: a comparison with findings of drug-sensitive tuberculosis[J]. J Comput Assist Tomogr, 2009, 33(6): 956-960.
[13] LI C H, FAN X, LV S X, et al.Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China[J]. Infect Drug Resist, 2023, 16: 651-659.
[14] CHENG N, WU S, LUO X, et al.A Comparative Study of Chest Computed Tomography Findings: 1030 Cases of Drug-Sensitive Tuberculosis versus 516 Cases of Drug-Resistant Tuberculosis[J]. Infect Drug Resist, 2021, 14: 1115-1128.
[15] 《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会结核病防治分会基础学组和临床分组, 吴雪琼, 等. 结核分枝杆菌耐药性检测专家共识[J]. 中国防痨杂志, 2019, 41(02): 129-137.
[16] GÜNTHER G, RUSWA N, KELLER P M. Drug-resistant tuberculosis: advances in diagnosis and management[J]. Curr Opin Pulm Med, 2022, 28(3): 211-217.
[17] SAMPATH P, RAJAMANICKAM A, THIRUVENGADAM K, et al.Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis[J]. Sci Rep, 2023, 13(1): 7404.
[18] 周新华. 从建立影像分析思路入手把握结核病影像诊断与鉴别要点[J]. 中国防痨杂志, 2020, 42(03): 191-194.
[19] XU C J, LU P X, LI C H, et al.Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis[J]. Quant Imaging Med Surg, 2024, 14(1): 1039-1060.
[20] 杨坤云, 郑正.110例耐多药肺结核肺部影像学分析[C]//中国防痨协会结核病控制专业委员会, 中国防痨协会. 中国防痨协会结核病控制专业委员会学术研讨会论文集, 2008: 65-66.
[21] 许传军, 陆普选, 何玉麟, 等. 耐药肺结核影像学诊断专家共识[J]. 新发传染病电子杂志, 2023, 8(05): 63-74.
[22] IHMS E A, URBANOWSKI M E, BISHAI W R J A J o P. Diverse Cavity Types and Evidence that Mechanical Action on the Necrotic Granuloma Drives Tuberculous Cavitation[J]. Am J Pathol, 2018, 188: 1666-1675.
[23] 韩萍. 耐药结核病的流行现状及其治疗[J]. 上海医药, 2022, 43(15): 3-5+9.
[24] 王梦梦, 沙莉, 于埼, 等. 耐多药结核患者生存质量现况调查及其影响因素分析[C]//中国防痨协会, 重庆智飞生物制品股份有限公司, 厦门致善生物科技股份有限公司. 中国防痨协会2023年第34届全国学术大会暨结核病诊防治新技术推广应用论坛论文汇编, 2023: 116-120.
[25] FANG W J, TANG S N, LIANG R Y, et al.Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: the Guangzhou computerized tomography study[J]. Quant Imaging Med Surg, 2024, 14(1): 1010-1021.
[26] 秦李祎, 吕平欣, 郭琳, 等. 基于CT图像的肺结核病灶治愈状态判定深度学习模型的建立[J]. 中国防痨杂志, 2024, 46(03): 272-278. |
|
|
|
2024, Vol. 21 
